Cascadia Advisory Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$594K Sell
7,005
-428
-6% -$35.9K 0.12% 166
2021
Q2
$620K Sell
7,433
-141
-2% -$11.5K 0.13% 154
2021
Q1
$570K Buy
+7,574
New +$552K 0.13% 152
2020
Q3
$620K Sell
10,621
-23,384
-69% -$1.46M 0.17% 148
2020
Q2
$2.21M Buy
+34,005
New +$2.14M 0.68% 40
2019
Q4
$2.08M Buy
+27,928
New +$1.96M 0.59% 48

Other funds holding CVS

Cascadia Advisory Services's CVS Position: Q3 2021 in Review

Cascadia Advisory Services reduced its CVS Health (CVS) stake by 5.8% in Q3 2021, selling an estimated $35.9K and leaving 7,005 shares worth $594K. The position accounts for 0.12% of the portfolio, ranked #166.

Cascadia Advisory Services first reported a position in CVS in Q4 2019 and has held it in 6 quarters since. The position peaked at $2.21M in Q2 2020. 2,073 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Cascadia Advisory Services held 7,005 shares of CVS Health worth $594K as of Q3 2021.
  • Cascadia Advisory Services sold 428 CVS Health shares in Q3 2021, an estimated $35.9K.
  • CVS Health made up 0.12% of Cascadia Advisory Services's portfolio in Q3 2021, its #166 holding.
  • Cascadia Advisory Services first reported a position in CVS Health in Q4 2019 and has held it in 6 quarters since.
  • Cascadia Advisory Services's CVS Health position peaked at $2.21M in Q2 2020.
  • 2,073 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Cascadia Advisory Services's 13F filing for Q3 2021, filed 12 Nov 2021.